Streamline Health Solutions, Inc. (STRM)
USD 2.0
(7.53%)
USD 2.0
(7.53%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.59 Million USD | -9.21% |
| 2022 | 24.88 Million USD | 43.21% |
| 2021 | 17.37 Million USD | 53.17% |
| 2020 | 11.34 Million USD | -45.3% |
| 2019 | 20.74 Million USD | -7.25% |
| 2018 | 22.36 Million USD | -8.11% |
| 2017 | 24.33 Million USD | -10.06% |
| 2016 | 27.05 Million USD | -4.43% |
| 2015 | 28.31 Million USD | 2.49% |
| 2014 | 27.62 Million USD | -3.05% |
| 2013 | 28.49 Million USD | 19.89% |
| 2012 | 23.76 Million USD | 38.86% |
| 2011 | 17.11 Million USD | -2.78% |
| 2010 | 17.6 Million USD | -3.31% |
| 2009 | 18.2 Million USD | 11.81% |
| 2008 | 16.28 Million USD | -1.68% |
| 2007 | 16.56 Million USD | 4.39% |
| 2006 | 15.86 Million USD | -1.61% |
| 2005 | 16.12 Million USD | 26.48% |
| 2004 | 12.75 Million USD | -0.41% |
| 2003 | 12.8 Million USD | -4.89% |
| 2002 | 13.46 Million USD | 23.07% |
| 2001 | 10.93 Million USD | 14.24% |
| 2000 | 9.57 Million USD | -8.8% |
| 1999 | 10.5 Million USD | -12.5% |
| 1998 | 12 Million USD | 37.93% |
| 1997 | 8.7 Million USD | -15.53% |
| 1996 | 10.3 Million USD | 106.0% |
| 1995 | 5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.33 Million USD | -19.23% |
| 2024 Q2 | 4.47 Million USD | 3.37% |
| 2023 FY | 22.59 Million USD | -9.21% |
| 2023 Q4 | 5.36 Million USD | -12.59% |
| 2023 Q3 | 6.13 Million USD | 6.29% |
| 2023 Q2 | 5.77 Million USD | 8.21% |
| 2023 Q1 | 5.33 Million USD | -20.95% |
| 2022 FY | 24.88 Million USD | 43.21% |
| 2022 Q2 | 5.99 Million USD | 0.96% |
| 2022 Q1 | 5.93 Million USD | -1.84% |
| 2022 Q3 | 6.21 Million USD | 3.76% |
| 2022 Q4 | 6.74 Million USD | 8.49% |
| 2021 FY | 17.37 Million USD | 53.17% |
| 2021 Q1 | 2.95 Million USD | -0.77% |
| 2021 Q3 | 5.51 Million USD | 92.26% |
| 2021 Q2 | 2.86 Million USD | -2.81% |
| 2021 Q4 | 6.04 Million USD | 9.65% |
| 2020 Q3 | 2.64 Million USD | -8.52% |
| 2020 FY | 11.34 Million USD | -45.3% |
| 2020 Q1 | 2.84 Million USD | -40.81% |
| 2020 Q2 | 2.88 Million USD | 1.51% |
| 2020 Q4 | 2.97 Million USD | 12.61% |
| 2019 Q1 | 5.35 Million USD | -1.98% |
| 2019 Q3 | 5.78 Million USD | 20.76% |
| 2019 Q2 | 4.79 Million USD | -10.53% |
| 2019 FY | 20.74 Million USD | -7.25% |
| 2019 Q4 | 4.8 Million USD | -16.98% |
| 2018 Q2 | 5.26 Million USD | -15.88% |
| 2018 FY | 22.36 Million USD | -8.11% |
| 2018 Q4 | 5.46 Million USD | 1.8% |
| 2018 Q3 | 5.36 Million USD | 1.9% |
| 2018 Q1 | 6.26 Million USD | 2.69% |
| 2017 Q3 | 6.39 Million USD | 8.17% |
| 2017 Q2 | 5.91 Million USD | -0.13% |
| 2017 Q4 | 6.09 Million USD | -4.69% |
| 2017 FY | 24.33 Million USD | -10.06% |
| 2017 Q1 | 5.92 Million USD | -7.2% |
| 2016 Q3 | 6.63 Million USD | -10.02% |
| 2016 Q1 | 6.66 Million USD | 4.65% |
| 2016 Q2 | 7.37 Million USD | 10.6% |
| 2016 Q4 | 6.38 Million USD | -3.8% |
| 2016 FY | 27.05 Million USD | -4.43% |
| 2015 Q3 | 7.15 Million USD | -16.99% |
| 2015 Q2 | 8.61 Million USD | 39.71% |
| 2015 FY | 28.31 Million USD | 2.49% |
| 2015 Q4 | 6.37 Million USD | -10.96% |
| 2015 Q1 | 6.16 Million USD | -6.46% |
| 2014 Q3 | 6.83 Million USD | -5.6% |
| 2014 Q1 | 6.95 Million USD | 6.67% |
| 2014 FY | 27.62 Million USD | -3.05% |
| 2014 Q2 | 7.24 Million USD | 4.18% |
| 2014 Q4 | 6.59 Million USD | -3.53% |
| 2013 Q4 | 6.51 Million USD | -3.19% |
| 2013 FY | 28.49 Million USD | 19.89% |
| 2013 Q3 | 6.73 Million USD | -23.27% |
| 2013 Q2 | 8.77 Million USD | 35.53% |
| 2013 Q1 | 6.47 Million USD | -3.93% |
| 2012 Q2 | 5.04 Million USD | -7.27% |
| 2012 Q3 | 6.53 Million USD | 29.42% |
| 2012 Q4 | 6.73 Million USD | 3.12% |
| 2012 FY | 23.76 Million USD | 38.86% |
| 2012 Q1 | 5.44 Million USD | 20.52% |
| 2011 Q4 | 4.51 Million USD | 4.78% |
| 2011 FY | 17.11 Million USD | -2.78% |
| 2011 Q3 | 4.31 Million USD | 4.01% |
| 2011 Q2 | 4.14 Million USD | 0.14% |
| 2011 Q1 | 4.14 Million USD | -15.76% |
| 2010 Q2 | 4.67 Million USD | 31.95% |
| 2010 Q3 | 4.47 Million USD | -4.4% |
| 2010 Q4 | 4.91 Million USD | 9.93% |
| 2010 FY | 17.6 Million USD | -3.31% |
| 2010 Q1 | 3.54 Million USD | -43.58% |
| 2009 Q4 | 6.28 Million USD | 52.99% |
| 2009 Q3 | 4.1 Million USD | 0.9% |
| 2009 Q2 | 4.06 Million USD | 8.5% |
| 2009 FY | 18.2 Million USD | 11.81% |
| 2009 Q1 | 3.75 Million USD | 8.21% |
| 2008 Q1 | 3.6 Million USD | -36.07% |
| 2008 FY | 16.28 Million USD | -1.68% |
| 2008 Q2 | 4.83 Million USD | 34.21% |
| 2008 Q4 | 3.46 Million USD | -20.84% |
| 2008 Q3 | 4.37 Million USD | -9.46% |
| 2007 FY | 16.56 Million USD | 4.39% |
| 2007 Q4 | 5.63 Million USD | 42.91% |
| 2007 Q3 | 3.94 Million USD | 23.13% |
| 2007 Q2 | 3.2 Million USD | -15.25% |
| 2007 Q1 | 3.77 Million USD | -1.67% |
| 2006 Q2 | 4.58 Million USD | 19.08% |
| 2006 FY | 15.86 Million USD | -1.61% |
| 2006 Q4 | 3.84 Million USD | 7.0% |
| 2006 Q3 | 3.59 Million USD | -21.62% |
| 2006 Q1 | 3.84 Million USD | -37.92% |
| 2005 Q3 | 3.16 Million USD | -22.16% |
| 2005 Q2 | 4.06 Million USD | 50.76% |
| 2005 FY | 16.12 Million USD | 26.48% |
| 2005 Q1 | 2.69 Million USD | -46.2% |
| 2005 Q4 | 6.19 Million USD | 95.91% |
| 2004 Q1 | 2.64 Million USD | -25.6% |
| 2004 Q3 | 2.53 Million USD | -0.78% |
| 2004 Q4 | 5.01 Million USD | 97.48% |
| 2004 Q2 | 2.55 Million USD | -3.15% |
| 2004 FY | 12.75 Million USD | -0.41% |
| 2003 Q1 | 2.61 Million USD | -33.64% |
| 2003 Q4 | 3.55 Million USD | -3.17% |
| 2003 Q3 | 3.66 Million USD | 23.6% |
| 2003 Q2 | 2.96 Million USD | 13.23% |
| 2003 FY | 12.8 Million USD | -4.89% |
| 2002 Q2 | 3.27 Million USD | 7.88% |
| 2002 Q1 | 3.03 Million USD | 10.6% |
| 2002 Q3 | 3.2 Million USD | -1.94% |
| 2002 Q4 | 3.94 Million USD | 23.05% |
| 2002 FY | 13.46 Million USD | 23.07% |
| 2001 Q1 | 2.71 Million USD | -3.77% |
| 2001 FY | 10.93 Million USD | 14.24% |
| 2001 Q3 | 3.38 Million USD | 61.28% |
| 2001 Q2 | 2.09 Million USD | -22.62% |
| 2001 Q4 | 2.74 Million USD | -18.98% |
| 2000 Q4 | 2.81 Million USD | 6.49% |
| 2000 FY | 9.57 Million USD | -8.8% |
| 2000 Q1 | 1.81 Million USD | -41.52% |
| 2000 Q3 | 2.64 Million USD | 15.19% |
| 2000 Q2 | 2.29 Million USD | 26.75% |
| 1999 Q2 | 2 Million USD | -16.67% |
| 1999 Q1 | 2.4 Million USD | -7.69% |
| 1999 FY | 10.5 Million USD | -12.5% |
| 1999 Q4 | 3.1 Million USD | 3.33% |
| 1999 Q3 | 3 Million USD | 50.0% |
| 1998 Q3 | 2.8 Million USD | -6.67% |
| 1998 Q2 | 3 Million USD | -16.67% |
| 1998 Q1 | 3.6 Million USD | 33.33% |
| 1998 FY | 12 Million USD | 37.93% |
| 1998 Q4 | 2.6 Million USD | -7.14% |
| 1997 Q4 | 2.7 Million USD | 17.39% |
| 1997 Q1 | 2.1 Million USD | 16.67% |
| 1997 FY | 8.7 Million USD | -15.53% |
| 1997 Q3 | 2.3 Million USD | 43.75% |
| 1997 Q2 | 1.6 Million USD | -23.81% |
| 1996 Q1 | 2.1 Million USD | -22.22% |
| 1996 FY | 10.3 Million USD | 106.0% |
| 1996 Q3 | 3 Million USD | -11.76% |
| 1996 Q4 | 1.8 Million USD | -40.0% |
| 1996 Q2 | 3.4 Million USD | 61.9% |
| 1995 Q4 | 2.7 Million USD | 285.71% |
| 1995 Q2 | 1.2 Million USD | 200.0% |
| 1995 Q3 | 700 Thousand USD | -41.67% |
| 1995 FY | 5 Million USD | 0.0% |
| 1995 Q1 | 400 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Omnicell, Inc. | 1.14 Billion USD | 98.03% |
| Renalytix Plc | 2.28 Million USD | -887.156% |
| Schrödinger, Inc. | 216.66 Million USD | 89.571% |
| Simulations Plus, Inc. | 70.01 Million USD | 67.726% |
| SOPHiA GENETICS SA | 62.37 Million USD | 63.772% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.744% |
| CareCloud, Inc. | 117.05 Million USD | 80.697% |
| HealthEquity, Inc. | 999.58 Million USD | 97.739% |
| iCoreConnect Inc. | 8.15 Million USD | -177.198% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 96.615% |
| Ontrak, Inc. | 12.74 Million USD | -77.321% |
| Minerva Surgical, Inc. | 50.29 Million USD | 55.072% |
| Nutex Health, Inc. | 247.64 Million USD | 90.876% |
| OneMedNet Corporation | 1.02 Million USD | -2111.714% |
| Progyny, Inc. | 1.08 Billion USD | 97.924% |
| Augmedix, Inc. | 44.85 Million USD | 49.624% |
| CareCloud, Inc. | 117.05 Million USD | 80.697% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.884% |
| Sharecare, Inc. | 445.25 Million USD | 94.925% |
| Aclarion, Inc. | 75.4 Thousand USD | -29866.58% |
| CareMax, Inc. | 751.1 Million USD | 96.992% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -34663.077% |
| Forian Inc. | 20.48 Million USD | -10.325% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -34663.077% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 88.845% |
| SCWorx Corp. | 3.8 Million USD | -493.859% |
| Definitive Healthcare Corp. | 251.41 Million USD | 91.012% |
| 10x Genomics, Inc. | 618.72 Million USD | 96.348% |
| Zhongchao Inc. | 19.43 Million USD | -16.271% |
| Accolade, Inc. | 414.29 Million USD | 94.546% |
| MSP Recovery, Inc. | 7.7 Million USD | -193.264% |
| R1 RCM Inc. | 2.25 Billion USD | 98.998% |
| Spok Holdings, Inc. | 139.02 Million USD | 83.747% |
| Privia Health Group, Inc. | 1.65 Billion USD | 98.637% |
| EUDA Health Holdings Limited | 3.7 Million USD | -509.639% |
| TruBridge, Inc. | 339.43 Million USD | 93.343% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.744% |
| Sharecare, Inc. | 445.25 Million USD | 94.925% |
| Health Catalyst, Inc. | 295.93 Million USD | 92.365% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 96.988% |
| Premier, Inc. | 1.34 Billion USD | 98.322% |
| HealthStream, Inc. | 279.06 Million USD | 91.903% |
| Certara, Inc. | 354.33 Million USD | 93.623% |
| GeneDx Holdings Corp. | 202.56 Million USD | 88.845% |
| Ontrak, Inc. | 12.74 Million USD | -77.321% |
| SHL Telemedicine Ltd. | 57.07 Million USD | 60.41% |
| CareCloud, Inc. | 117.05 Million USD | 80.697% |
| EUDA Health Holdings Limited | 3.7 Million USD | -509.639% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -2989.025% |
| CareMax, Inc. | 751.1 Million USD | 96.992% |
| Healthcare Triangle, Inc. | 33.2 Million USD | 31.946% |
| National Research Corporation | 148.58 Million USD | 84.792% |
| Aclarion, Inc. | 75.4 Thousand USD | -29866.58% |
| OptimizeRx Corporation | 71.52 Million USD | 68.407% |